These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 27836402)

  • 21. Fluorinated benzophenone derivatives: balanced multipotent agents for Alzheimer's disease.
    Belluti F; De Simone A; Tarozzi A; Bartolini M; Djemil A; Bisi A; Gobbi S; Montanari S; Cavalli A; Andrisano V; Bottegoni G; Rampa A
    Eur J Med Chem; 2014 May; 78():157-66. PubMed ID: 24681980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. beta-Secretase as a therapeutic target for Alzheimer's disease.
    Ghosh AK; Gemma S; Tang J
    Neurotherapeutics; 2008 Jul; 5(3):399-408. PubMed ID: 18625451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design and synthesis of tricyclic sulfones as gamma-secretase inhibitors with greatly reduced Notch toxicity.
    Xu R; Cole D; Asberom T; Bara T; Bennett C; Burnett DA; Clader J; Domalski M; Greenlee W; Hyde L; Josien H; Li H; McBriar M; McKittrick B; McPhail AT; Pissarnitski D; Qiang L; Rajagopalan M; Sasikumar T; Su J; Tang H; Wu WL; Zhang L; Zhao Z
    Bioorg Med Chem Lett; 2010 Apr; 20(8):2591-6. PubMed ID: 20236824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic intervention for Alzheimer's disease with γ-secretase inhibitors: still a viable option?
    Imbimbo BP; Panza F; Frisardi V; Solfrizzi V; D'Onofrio G; Logroscino G; Seripa D; Pilotto A
    Expert Opin Investig Drugs; 2011 Mar; 20(3):325-41. PubMed ID: 21222550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural optimization of a CXCR2-directed antagonist that indirectly inhibits gamma-secretase and reduces Abeta.
    Bakshi P; Jin C; Broutin P; Berhane B; Reed J; Mullan M
    Bioorg Med Chem; 2009 Dec; 17(23):8102-12. PubMed ID: 19853461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Are γ-secretase inhibitors detrimental for Alzheimer's disease patients?
    Ross JS; Imbimbo BP
    J Alzheimers Dis; 2010; 22(2):401-4. PubMed ID: 21149978
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design and synthesis of bicyclic heterocycles as potent γ-secretase modulators.
    Oehlrich D; Rombouts FJ; Berthelot D; Bischoff FP; De Cleyn MA; Jaroskova L; Macdonald G; Mercken M; Surkyn M; Trabanco AA; Tresadern G; Van Brandt S; Velter AI; Wu T; Gijsen HJ
    Bioorg Med Chem Lett; 2013 Sep; 23(17):4794-800. PubMed ID: 23890837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design, synthesis and SAR analysis of potent BACE1 inhibitors: Possible lead drug candidates for Alzheimer's disease.
    Tarazi H; Odeh RA; Al-Qawasmeh R; Yousef IA; Voelter W; Al-Tel TH
    Eur J Med Chem; 2017 Jan; 125():1213-1224. PubMed ID: 27871037
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological evidences for DFK167-sensitive presenilin-independent gamma-secretase-like activity.
    Sevalle J; Ayral E; Hernandez JF; Martinez J; Checler F
    J Neurochem; 2009 Jul; 110(1):275-83. PubMed ID: 19457123
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Secretase inhibitors and modulators for Alzheimer's disease treatment.
    Tomita T
    Expert Rev Neurother; 2009 May; 9(5):661-79. PubMed ID: 19402777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gamma Secretase Modulators: New Alzheimer's Drugs on the Horizon?
    Bursavich MG; Harrison BA; Blain JF
    J Med Chem; 2016 Aug; 59(16):7389-409. PubMed ID: 27007185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fluoro-benzimidazole derivatives to cure Alzheimer's disease: In-silico studies, synthesis, structure-activity relationship and in vivo evaluation for β secretase enzyme inhibition.
    Ali S; Asad MHHB; Maity S; Zada W; Rizvanov AA; Iqbal J; Babak B; Hussain I
    Bioorg Chem; 2019 Jul; 88():102936. PubMed ID: 31054426
    [No Abstract]   [Full Text] [Related]  

  • 33. 3-Substituted gem-cyclohexane sulfone based gamma-secretase inhibitors for Alzheimer's disease: conformational analysis and biological activity.
    Jelley RA; Elliott J; Gibson KR; Harrison T; Beher D; Clarke EE; Lewis HD; Shearman M; Wrigley JD
    Bioorg Med Chem Lett; 2006 Jul; 16(14):3839-42. PubMed ID: 16682202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The novel gamma secretase inhibitor N-[cis-4-[(4-chlorophenyl)sulfonyl]-4-(2,5-difluorophenyl)cyclohexyl]-1,1,1-trifluoromethanesulfonamide (MRK-560) reduces amyloid plaque deposition without evidence of notch-related pathology in the Tg2576 mouse.
    Best JD; Smith DW; Reilly MA; O'Donnell R; Lewis HD; Ellis S; Wilkie N; Rosahl TW; Laroque PA; Boussiquet-Leroux C; Churcher I; Atack JR; Harrison T; Shearman MS
    J Pharmacol Exp Ther; 2007 Feb; 320(2):552-8. PubMed ID: 17099072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In silico prediction and screening of gamma-secretase inhibitors by molecular descriptors and machine learning methods.
    Yang XG; Lv W; Chen YZ; Xue Y
    J Comput Chem; 2010 Apr; 31(6):1249-58. PubMed ID: 19847781
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure-based design, synthesis, and biological evaluation of dihydroquinazoline-derived potent β-secretase inhibitors.
    Ghosh AK; Pandey S; Gangarajula S; Kulkarni S; Xu X; Rao KV; Huang X; Tang J
    Bioorg Med Chem Lett; 2012 Sep; 22(17):5460-5. PubMed ID: 22863204
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, synthesis, in silico and in vitro screening of 1,2,4-thiadiazole analogues as non-peptide inhibitors of beta-secretase.
    Gurjar AS; Andrisano V; Simone AD; Velingkar VS
    Bioorg Chem; 2014 Dec; 57():90-98. PubMed ID: 25303313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advances in gamma-secretase modulation.
    Pissarnitski D
    Curr Opin Drug Discov Devel; 2007 Jul; 10(4):392-402. PubMed ID: 17659480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery of gamma-secretase inhibitors efficacious in a transgenic animal model of Alzheimer's disease.
    Asberom T; Zhao Z; Bara TA; Clader JW; Greenlee WJ; Hyde LA; Josien HB; Li W; McPhail AT; Nomeir AA; Parker EM; Rajagopalan M; Song L; Wong GT; Zhang L; Zhang Q; Pissarnitski DA
    Bioorg Med Chem Lett; 2007 Jan; 17(2):511-6. PubMed ID: 17079141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BIIB042, a novel γ-secretase modulator, reduces amyloidogenic Aβ isoforms in primates and rodents and plaque pathology in a mouse model of Alzheimer's disease.
    Scannevin RH; Chollate S; Brennan MS; Snodgrass-Belt PA; Peng H; Xu L; Jung MY; Bussiere T; Arastu MF; Talreja T; Xin Z; Dunstan RW; Fahrer D; Rohde E; Dunah AW; Wang J; Kumaravel G; Taveras AG; Moore Arnold H; Rhodes KJ
    Neuropharmacology; 2016 Apr; 103():57-68. PubMed ID: 26690893
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.